Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: SIGMA-ALDRICH, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-09-20 to 2026-03-22
Current total value of award: $1249000
Description: RESEARCH DEVELOPMENT FOR DRUG MANUFACTURING OF PHASE 2 AND 3 ARMY LIPOSOME FORMULATION CONTAINING QS-21 UNDER CURRENT GOOD MANUFACTURING PRACTICES